Skip to main content
SpringerLink
Log in

Is there any genetic predisposition of MMP-9 gene C1562T and MTHFR gene C677T polymorphisms with essential hypertension?

  • Original Research
  • Published:
Cytotechnology Aims and scope Submit manuscript

Abstract

The current study was conducted to determine whether there is a relation between hypertension and two different polymorphisms, including C1562T of the Matrix metalloproteinase-9 (MMP-9) gene and C677T of the methylenetetrahydrofolate reductase (MTHFR) gene. Genomic DNA obtained from 224 persons (125 patients with hypertension and 99 healthy controls) were used in the study. Polymorphisms were determined by using polymerase chain reaction-restriction fragment length polymorphism and electrophoresis. The results were statistically analyzed and were found to be statistically significant. The frequencies of the C1562T genotypes were found to be, in controls CC 75.8 % and CT 24.2 % and in patients CC 71.2 %, and CT 28.8 %. The frequencies of C677T genotype were found to be, in controls CC 56.6 %, CT 38.4 and TT 5.1 % in controls and in patients CC 52 %, CT 30.4 % and TT 17.6 %. In conclusion, we may suggest that there is no relation between the essential hypertension and C1562T polymorphism of MMP-9 gene; on the other hand C677T polymorphism (genotype TT) of MTHFR gene can be regarded as a genetic indicator for the development of essential hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Apakkan Aksun AS, Ozmen D, Bayındır O (2001) Metalloproteınases, theır ınhıbıtors and related physıologıcal and pathologıcal condıtıons. T Klin J Med Sci 21:332–342

    Google Scholar 

  • Bayramoglu A, Gunes HV, Metintas M, Degirmenci I, Mutlu F, Alatas F (2009) The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer. Genet Test Mol Biomarks 13:671–678

    Article  CAS  Google Scholar 

  • Bayramoglu A, Gunes HV, Metintas M, Degirmenci I, Akın A, Kurt H (2010) Is a single nucleotide polymorphism a risk factor for lung cancer in the matrix metalloproteinase-2 promoter? Mol Biol Rep 38:1469–1474

    Google Scholar 

  • Bayramoglu A, Gunes HV, Metintas M, Degirmenci I, Akın A, Kurt H (2011) Is a single nucleotide polymorphism a risk factor for lung cancer in the matrix metalloproteinase-2 promoter? Mol Biol Rep 38:1469–1474

    Google Scholar 

  • Bayramoglu A, Kucuk Urhan M, Ercan S, Abacı O, Guler HI, Kucukkaya Y, Korkmaz MC (2012) Hypertension and matrix metalloproteinase-9 enzyme activity. J Selcuk Univ Natur Appl Sci 3:60–68

    Google Scholar 

  • Berg G, Miksztowicz V, Schreier L (2011) Metalloproteinases in metabolic syndrome. Clin Chim Acta 412:1731–1739

    Article  CAS  Google Scholar 

  • Bova I, Chapman J, Sylantiev C, Korczyn AD, Bornstein NM (1999) The A677C methylenetetrahydrofolate reductase gene polymorphism and carotid atherosclerosis. Stroke 30:2180–2182

    Article  CAS  Google Scholar 

  • Chintala SK, Tonn JC, Rao JS (1999) Matrix metalloproteinases and their biological function in human gliomas. Int J Dev Neurosci 17:495–502

    Google Scholar 

  • Corbel M, Boichot E, Langente V (2000) Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz J Med Biol Res 33:749–754

    Article  CAS  Google Scholar 

  • Daly SF, Molloy AM, Mills JL, Lee YJ, Conley M, Kirke PN, Weir DG, Scott JM (1999) The influence of 5, 10 methylenetetrahydrofolate reductase genotypes on enzyme activity in placental tissue. Brit J Obstet Gynaecol 106:1214–1218

    Article  CAS  Google Scholar 

  • De Souza AP, Trevillato RM, Scarel-Caminaga RM, De Brito RB, Barros SP, Line SRP (2005) Analysis of the MMP-9 (C1562T) And TIMP-2 (G418C) gene promotör polymorphisims in patients with chronic periodontitis. J Clin Periodontol 32:207–211

    Article  Google Scholar 

  • Derosa G, D’Angelo A, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo S, Montagna L, Gravina A, Ferrari I, Galli S, Paniga S, Tinelli C, Cicero AF (2006) Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. Endothelium 13:227–231

    Article  CAS  Google Scholar 

  • Dikmen M, Gülel B, Günes HV, Gücüyener D, Degırmencı I, Ozdemir G, Basaran A (2004) The effect of MTHFR gene polymorphisms on the homocysteine level, a risk factor, in acute stroke patients. Kocatepe Med J 5:55–61

    Google Scholar 

  • Fontana V, Silva PS, Belo VA, Antonio RC, Ceron CS, Biagi C, Gerlach RF, Tanus-Santos JE (2011) Consistent alterations of circulating matrix metalloproteinases levels in untreated hypertensives and in spontaneously hypertensive rats: a relevant pharmacological target. Basic Clin Pharmacol Toxicol 109:130–137

    Article  CAS  Google Scholar 

  • Friese RS, Rao F, Khandrika S, Thomas B, Ziegler MG, Schmid-Schönbein GW, O’Connor DT (2009) Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease. Clin Exp Hypertens 31:521–533

    Article  CAS  Google Scholar 

  • Gai X, Lan X, Luo Z, Wang F, Liang Y, Zhang H, Zhang W, Hou J, Huang M (2009) Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients. Clin Chim Acta 408:105–109

    Article  CAS  Google Scholar 

  • Goyette P, Rozen R (2000) The thermolabile variant 677CT can further reduce activity when expressed in CIS with severe mutations for human methylenetetrahydrofolate reductase. Hum Mutat 16:132–138

    Article  CAS  Google Scholar 

  • Gunes HV, Ata N, Degırmencı I, Basaran A, Tımuralp B, Dıkmen M, Ustuner C, Kudaıberdıeva G (2004) Frequency of angiotensin-converting enzyme gene polymorphism in Turkish hypertensive patients. Int J Clin Pract 58:838–843

    Article  CAS  Google Scholar 

  • Heux S, Morın F, Lea RA, Ovcaric M, Tajouri L, Griffiths LR (2004) The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians. Hypertens Res 27:663–667

    Article  CAS  Google Scholar 

  • Homberger G, Linnebank M, Winter C, Willenbring H, Marquardt T, Harms E, Koch HG (2000) Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene. Eur J Hum Genet 8:725–729

    Article  CAS  Google Scholar 

  • Huhtala P, Chows LT, Tryggvason K (1990) Structure of the human type IV collagenase gene. J Biol Chem 265:11077–11082

    CAS  Google Scholar 

  • Hulyam K, Aysegul B, Veysi GH, Demet O, Irfan D, Ertugrul C, Didem CT, Banu B, Miris D (2013) Frequency of angiotensin II type 1 receptor gene polymorphism in Turkish acute stroke patients. J Cell Mol Med 17:475–481

    Article  CAS  Google Scholar 

  • Humphrey D (2008) Mechanisms of arterial remodelling in hypertension: coupled roles of wall shear an intramural stress. Hypertension 52:195–200

    Article  CAS  Google Scholar 

  • Ilhan N, Kucuksu M, Kaman D, Ilhan N, Ozbay Y (2008) The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels. Arch Med Res 39:125–130

    Article  CAS  Google Scholar 

  • Kang S, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N (1991) Thermolabile methylenetetrahydrofolate reductase: an ınherited risk factor for coronary artery disease. J Hum Genet 48:536–545

    CAS  Google Scholar 

  • Kleiner DE, Stetler-Stevenson WG (1999) Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 43:42–51

    Article  Google Scholar 

  • Koo HS, Lee HL, Hong YM (2008) Methylenetetrahydrofolate reductase TT genotype as a predictor of cardiovascular risk in hypertensive adolescents. Pediatr Cardiol 29:136–141

    Article  Google Scholar 

  • Kosmas IP, Tatsioni A, Ioannidis JPA (2004) Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 22:1655–1662

    Article  CAS  Google Scholar 

  • Lacchini R, Jacob-Ferreira ALB, Luizon MR, Coeli FB, Izidoro-Toledo TC, Gasparini S, Ferreira-Sae MC, Schreiber R, Nadruz W, Tanus-Santos JE (2010) Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients. Clin Chim Acta 411:1940–1944

    Article  CAS  Google Scholar 

  • Lee H, Choi J, Ha K, Yang DH, Chang SK, Hong SY (1999) Influence of 5, 10- methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine concentration in patients with end-stage renal disease. Am J Kidney Dis 34:259–263

    Article  CAS  Google Scholar 

  • Lifton RP, Gharavi AG, Geller DS (2001) Molecular mechanisms of human hypertension. Cell 104:545–556

    Article  CAS  Google Scholar 

  • Markan S, Sachdeva M, Sehrawat BS, Kumari S, Jain S, Khullar M (2007) MTHFR 677 CT/MTHFR 1298 CC genotypes are associated with increased risk of hypertension in Indians. Mol Cell Biochem 302:125–131

    Article  CAS  Google Scholar 

  • Martinez ML, Lopes LF, Coelho EB, Nobre F, Rocha JB, Gerlach RF, Tanus-Santos JE (2006) Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension. J Cardiovasc Pharmacol 47:117–122

    Article  CAS  Google Scholar 

  • Nguyen M, Aekell J, Jackson C (2001) Human endotelhial gelatinases and angiogenesis. Int J Biochem Cell Biol 33:960–970

    Article  CAS  Google Scholar 

  • O’Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D (1998) Evidence for association and genetic linkage of the angiotensin converting enzyme locus with hypertansion and blood pressure in men but women in the framingham heart study. Circulation 97:1766–1772

    Article  Google Scholar 

  • Palei ACT, Sandrim VC, Duarte G, Cavalli RC, Gerlach RF, Tanus-Santos JE (2010) Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension. Clin Chim Acta 411:874–877

    Article  CAS  Google Scholar 

  • Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli RC, Lacchini R, Duarte G, Tanus-Santos JE (2012) Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. Pharmacogenomics J 12:489–498

    Article  CAS  Google Scholar 

  • Qian X, Lu Z, Tan M, Liu H, Lu D (2007) A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. Eur J Hum Genet 15:1239–1245

    Article  CAS  Google Scholar 

  • Rosenblatt DS (2001) Methylenetetrahydrofolate reductase. Clin Invest Med 24:56–59

    CAS  Google Scholar 

  • Schmitz C, Lindpainter K, Verhoef P, Gaziano JM, Buring J (1996) Geneticpolymorphism of methylenetetrahydrofolate reductase and myocardial infarction. Circulation 94:1812–1814

    Article  CAS  Google Scholar 

  • Schneider JA, Rees DC, Liu YT, Clegg JB (1998) Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet 62:1258–1260

    Article  CAS  Google Scholar 

  • Song WH, Dang AM, Zhu JM, Lü NQ, Liu GZ, Hui RT (2006) MMP-9 gene -1562C/T polymorphism in aortic dissection in Chinese hypertensive patients. Zhonghua Nei Ke Za Zhi 45:376–378

    CAS  Google Scholar 

  • Stern LL, Bagley PJ, Rosenberg IH, Selhub J (2000) Conversion of 5-formyltetrahydrofolic acid is unimpaired in folate- adequate persons homozygous for the C677T mutation in the methylenetetrahydrofolate reductase gene. J Nutr 130:2238–2242

    CAS  Google Scholar 

  • Zhou S, Feely J, Spiers JP, Mahmud A (2007) Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension MMP-9 gene and arterial stiffness in hypertension. J Hum Hypertens 21:861–867

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biology, Science and Art Faculty, Artvin Coruh University, 08000, Artvin, Turkey

    Aysegul Bayramoglu & Halıl Ibrahim Guler

  2. Department of Medical Biology, Faculty of Medicine, Mustafa Kemal University, Antakya, Turkey

    Meral Urhan Kucuk

  3. Institute of Cardiology, Istanbul University, Haseki-Fatih, Turkey

    Okay Abaci

  4. Department of Biology, Science and Art Faculty, Adiyaman University, Adiyaman, Turkey

    Yunus Kucukkaya

  5. Department of Biostatistics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey

    Ertugrul Colak

Authors
  1. Aysegul Bayramoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meral Urhan Kucuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Halıl Ibrahim Guler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Okay Abaci
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yunus Kucukkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ertugrul Colak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aysegul Bayramoglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bayramoglu, A., Urhan Kucuk, M., Guler, H.I. et al. Is there any genetic predisposition of MMP-9 gene C1562T and MTHFR gene C677T polymorphisms with essential hypertension?. Cytotechnology 67, 115–122 (2015). https://doi.org/10.1007/s10616-013-9665-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10616-013-9665-0

Keywords

Search

Navigation